24.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt PHG?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$24.60
Offen:
$24.46
24-Stunden-Volumen:
773.58K
Relative Volume:
0.74
Marktkapitalisierung:
$23.63B
Einnahmen:
$19.49B
Nettoeinkommen (Verlust:
$-757.52M
KGV:
-31.12
EPS:
-0.7885
Netto-Cashflow:
-
1W Leistung:
+2.08%
1M Leistung:
+10.09%
6M Leistung:
-7.64%
1J Leistung:
-5.14%
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Firmenname
Koninklijke Philips N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PHG mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PHG
Koninklijke Philips N V Adr
|
24.54 | 22.24B | 19.49B | -757.52M | 0 | -0.7885 |
![]()
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-25 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
2025-02-20 | Hochstufung | UBS | Neutral → Buy |
2024-10-29 | Hochstufung | Jefferies | Underperform → Hold |
2024-05-13 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2024-05-07 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
2024-04-30 | Hochstufung | JP Morgan | Underweight → Neutral |
2024-04-30 | Hochstufung | UBS | Sell → Neutral |
2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
2023-07-12 | Eingeleitet | Goldman | Buy |
2023-01-17 | Herabstufung | UBS | Neutral → Sell |
2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-10-14 | Herabstufung | Deutsche Bank | Hold → Sell |
2022-09-12 | Hochstufung | Societe Generale | Hold → Buy |
2022-09-06 | Hochstufung | UBS | Sell → Neutral |
2022-07-25 | Herabstufung | Societe Generale | Buy → Hold |
2022-06-16 | Herabstufung | UBS | Neutral → Sell |
2022-01-20 | Herabstufung | Jefferies | Buy → Hold |
2022-01-14 | Hochstufung | HSBC Securities | Hold → Buy |
2022-01-12 | Herabstufung | Citigroup | Buy → Neutral |
2021-09-08 | Eingeleitet | Jefferies | Buy |
2021-07-08 | Herabstufung | Deutsche Bank | Buy → Hold |
2021-06-21 | Herabstufung | HSBC Securities | Buy → Hold |
2021-03-18 | Hochstufung | JP Morgan | Neutral → Overweight |
2020-07-28 | Eingeleitet | Societe Generale | Buy |
2019-07-30 | Eingeleitet | Citigroup | Buy |
2018-02-12 | Hochstufung | Berenberg | Hold → Buy |
2017-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
2017-10-16 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
2017-06-21 | Herabstufung | Natixis Bleichroeder | Buy → Neutral |
2017-04-25 | Herabstufung | Societe Generale | Buy → Hold |
2016-12-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2016-11-23 | Eingeleitet | Citigroup | Buy |
2016-05-11 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
2016-03-01 | Hochstufung | HSBC Securities | Reduce → Hold |
2016-02-16 | Herabstufung | Jefferies | Hold → Underperform |
2015-11-27 | Eingeleitet | ING Group | Hold |
2015-09-08 | Eingeleitet | Credit Suisse | Outperform |
2015-08-27 | Hochstufung | Nomura | Neutral → Buy |
2015-07-28 | Hochstufung | Societe Generale | Hold → Buy |
2011-01-25 | Herabstufung | HSBC Securities | Overweight → Neutral |
2009-12-07 | Hochstufung | Deutsche Bank | Hold → Buy |
2009-10-16 | Hochstufung | HSBC Securities | Neutral → Overweight |
2009-05-08 | Herabstufung | UBS | Buy → Neutral |
Alle ansehen
Koninklijke Philips N V Adr Aktie (PHG) Neueste Nachrichten
Sleep Apnea Devices Market is expected to generate a revenue of USD 14.59 Billion by 2031, Globally, at 10.42 % CAGR: Verified Market Research® - GlobeNewswire Inc.
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Sony Group Corp. ADR rises Wednesday, still underperforms market - MarketWatch
Sony Group Corp. ADR outperforms market despite losses on the day - MarketWatch
Sony Group Corp. ADR rises Thursday, outperforms market - MarketWatch
CBRE Group Inc (CBRE) Stock: A Closer Look at the Market Potential - News Heater
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
Taiwan Air Treatment Systems Industry Report: From AIoT to Wearables - GlobeNewswire Inc.
Sony Group Corp. ADR rises Friday, outperforms market - MarketWatch
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
Selling Your Koninklijke Philips N.V. ADR (PHG) Stock? Here’s What You Need To Know - Stocks Register
Data-Based Insights About Koninklijke Philips N.V. ADR (PHG) - Stocks Register
Koninklijke Philips N.V. ADR (PHG) Shares Up Despite Recent Market Volatility - The News Heater
P3 Health Partners Inc (PIII) Stock: Evaluating the Annual Growth - The News Heater
Nabors Industries Ltd (NBR) Stock: A SWOT Analysis - The News Heater
Sun Country Airlines Holdings Inc (SNCY) Stock: A Value Analysis - The News Heater
Sony Group Corp. ADR outperforms market on strong trading day - MarketWatch
Weekly Upgrades and Downgrades - InvestorPlace
Sony Group Corp. ADR falls Monday, underperforms market - MarketWatch
Europe Cancer Diagnostics Market Size & Outlook, 2024-2030 - Grand View Research
Sony Group Corp. ADR outperforms competitors on strong trading day - MarketWatch
Sony Group Corp. ADR underperforms Thursday when compared to competitors - MarketWatch
Philips Avent Enters the Smart Parenting Category with the launch of its most advanced baby monitor: the Premium Connected Baby Monitor - Ariva
PHG vs. ESLOY: Which Stock Is the Better Value Option? - Yahoo Finance
China Operating Room Equipment Market Size & Outlook, 2030 - Grand View Research
New 4-Star Stocks - Morningstar
Philips to repurchase shares for up to $137.4M - Mass Device
Philips wins FDA clearance for next-gen digital pathology system - Mass Device
GE HealthCare: Initiating Coverage With Wide Moat, Shares Look Attractive - Morningstar
Philips unveils new AI-powered cardiovascular ultrasound - Mass Device
Philips prices $758.6M offering, expands access to intracardiac echocardiography - Mass Device
Philips has positive AI-powered cardiac monitoring data - Mass Device
Finanzdaten der Koninklijke Philips N V Adr-Aktie (PHG)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):